CLREX | RLBGX | CLREX / RLBGX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 14 years | 16 years | - |
Gain YTD | 1.209 | 1.980 | 61% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 9.75B | 240B | 4% |
Annual Yield % from dividends | 1.96 | 2.55 | 77% |
Returns for 1 year | 10.38 | 12.67 | 82% |
Returns for 3 years | 10.09 | 13.23 | 76% |
Returns for 5 years | 24.13 | 31.72 | 76% |
Returns for 10 years | 60.24 | 59.02 | 102% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FNGS | 57.97 | 0.96 | +1.68% |
MicroSectors™ FANG+™ ETN | |||
HDUS | 57.68 | 0.54 | +0.95% |
Hartford Disciplined US Equity ETF | |||
GHTA | 28.54 | 0.10 | +0.37% |
Goose Hollow Tactical Allocation ETF | |||
DES | 34.73 | 0.07 | +0.20% |
WisdomTree US SmallCap Dividend ETF | |||
BIS | 18.25 | N/A | N/A |
ProShares UltraShort Nasdaq Biotech |